115 related articles for article (PubMed ID: 28715002)
1. Cationic folate-mediated liposomal delivery of bis-arylidene oxindole induces efficient melanoma tumor regression.
Elechalawar CK; Sridharan K; Pal A; Ahmed MT; Yousuf M; Adhikari SS; Banerjee R
Biomater Sci; 2017 Aug; 5(9):1898-1909. PubMed ID: 28715002
[TBL] [Abstract][Full Text] [Related]
2. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
[TBL] [Abstract][Full Text] [Related]
3. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells.
Gupta Y; Jain A; Jain P; Jain SK
J Drug Target; 2007 Apr; 15(3):231-40. PubMed ID: 17454361
[TBL] [Abstract][Full Text] [Related]
4. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
Chiu SJ; Marcucci G; Lee RJ
Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
[TBL] [Abstract][Full Text] [Related]
5. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes.
Kabilova TO; Shmendel EV; Gladkikh DV; Chernolovskaya EL; Markov OV; Morozova NG; Maslov MA; Zenkova MA
Eur J Pharm Biopharm; 2018 Feb; 123():59-70. PubMed ID: 29162508
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid
Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G
Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
[TBL] [Abstract][Full Text] [Related]
9. Delivery of chemotherapeutic drug targeting folate receptor to oral cancer cells using functionalized carbon nanospheres.
Bhattacharya D; Sakhare K; Dhiman C; Ansari A; Kundu TK; Narayan KP; Banerjee R
Biomed Mater; 2023 Aug; 18(5):. PubMed ID: 37467764
[TBL] [Abstract][Full Text] [Related]
10. Folate receptor targeted NIR cleavable liposomal delivery system augment penetration and therapeutic efficacy in breast cancer.
Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130396. PubMed ID: 37271407
[TBL] [Abstract][Full Text] [Related]
11. Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting.
Ye P; Zhang W; Yang T; Lu Y; Lu M; Gai Y; Ma X; Xiang G
Int J Nanomedicine; 2014; 9():2167-78. PubMed ID: 24855354
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of a novel lipophilic folate receptor targeting ligand.
Liu Y; Xu S; Teng L; Yung B; Zhu J; Ding H; Lee RJ
Anticancer Res; 2011 May; 31(5):1521-5. PubMed ID: 21617205
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages.
Hattori Y; Yamashita J; Sakaida C; Kawano K; Yonemochi E
J Liposome Res; 2015; 25(2):131-40. PubMed ID: 25203609
[TBL] [Abstract][Full Text] [Related]
14. Functional coating of liposomes using a folate- polymer conjugate to target folate receptors.
Watanabe K; Kaneko M; Maitani Y
Int J Nanomedicine; 2012; 7():3679-88. PubMed ID: 22888227
[TBL] [Abstract][Full Text] [Related]
15. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
16. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model.
Pan XQ; Lee RJ
Anticancer Res; 2005; 25(1A):343-6. PubMed ID: 15816557
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G
J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163
[TBL] [Abstract][Full Text] [Related]
18. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
Leamon CP; Cooper SR; Hardee GE
Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
[TBL] [Abstract][Full Text] [Related]
19. Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone.
Kawano K; Onose E; Hattori Y; Maitani Y
Mol Pharm; 2009; 6(1):98-104. PubMed ID: 19072653
[TBL] [Abstract][Full Text] [Related]
20. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
